<DOC>
	<DOCNO>NCT00724243</DOCNO>
	<brief_summary>This study gather information safety efficacy patient rheumatoid arthritis ( RA ) start treatment infliximab first time . Patients treat usual manner accord local guideline normal clinical practice .</brief_summary>
	<brief_title>Safety Effectiveness Infliximab Slovakia When Used Rheumatoid Arthritis ( Study P04741 ) ( COMPLETED )</brief_title>
	<detailed_description>Local patient , diagnose RA National Institute Rheumatic Diseases , Piestany , Slovakia , participate , physician decide treat patient infliximab . Registration trial do voluntary basis .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Subject must give patient leaflet , Subject must ever receive infliximab time registration , Subject must good candidate infliximab per Summary Product Characteristics Subject must sign approved consent form</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>